These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9152413)

  • 1. Long-term non-progressive human immunodeficiency virus infection: new insights from the simian immunodeficiency virus model.
    Dittmer U; Hunsmann G
    J Gen Virol; 1997 May; 78 ( Pt 5)():979-84. PubMed ID: 9152413
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular immune response to SIVmac and HIV-2 in macaques: model for the human HIV-1 infection.
    Voss G; Hunsmann G
    J Acquir Immune Defic Syndr (1988); 1993 Sep; 6(9):969-76. PubMed ID: 8340900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic T lymphocytes in AIDS pathogenesis: lessons to be learned from the macaque model of simian immunodeficiency virus infection.
    Geretti AM; Hulskotte E; Osterhaus AD
    J Gen Virol; 1998 Mar; 79 ( Pt 3)():415-21. PubMed ID: 9519818
    [No Abstract]   [Full Text] [Related]  

  • 4. CTL ontogeny and viral escape: implications for HIV-1 vaccine design.
    Yang OO
    Trends Immunol; 2004 Mar; 25(3):138-42. PubMed ID: 15036041
    [No Abstract]   [Full Text] [Related]  

  • 5. Current world literature.
    Curr Opin HIV AIDS; 2010 Mar; 5(2):194-200. PubMed ID: 20539072
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity.
    Kent SJ; Fernandez CS; Dale CJ; Davenport MP
    Trends Microbiol; 2005 Jun; 13(6):243-6. PubMed ID: 15936652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The primate connection.
    Trivedi B
    Nature; 2010 Jul; 466(7304):S5. PubMed ID: 20631704
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytotoxic T-cell epitopes in HIV/SIV infection.
    Venet A; Walker BD
    AIDS; 1993; 7 Suppl 1():S117-26. PubMed ID: 7689848
    [No Abstract]   [Full Text] [Related]  

  • 9. Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys.
    Voss G; Li J; Manson K; Wyand M; Sodroski J; Letvin NL
    Virology; 1995 Apr; 208(2):770-5. PubMed ID: 7747449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTL responses to HIV and SIV: wrestling with smoke.
    John M; Mallal S
    Nat Immunol; 2005 Mar; 6(3):232-4. PubMed ID: 15716970
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of virus-specific immune responses in SHIV(KU)-infected macaques treated with PMPA.
    Kumar A; Buch S; Foresman L; Bischofberger N; Lifson JD; Narayan O
    Virology; 2001 Jan; 279(1):97-108. PubMed ID: 11145893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of IL-17-producing CD8 T cells during late chronic stage of pathogenic simian immunodeficiency virus infection.
    Nigam P; Kwa S; Velu V; Amara RR
    J Immunol; 2011 Jan; 186(2):745-53. PubMed ID: 21148794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MHC-I non-restricted cytotoxic activity in Macaca sylvana experimentally inoculated with HIV2 and SIV/mac.
    Charaf B; Sanhadji K; Sekkat S; Farouqui B; Touraine JL; Benslimane A
    Thymus; 1993 Aug; 22(1):1-12. PubMed ID: 7905683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th17 cells, HIV and the gut mucosal barrier.
    Dandekar S; George MD; Bäumler AJ
    Curr Opin HIV AIDS; 2010 Mar; 5(2):173-8. PubMed ID: 20543596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The immunological manifestations and cytological characteristics of infection caused by the simian immunodeficiency virus (SIV) in rhesus monkeys].
    Persidskiĭ IuV; Shcherbinskaia AM; Barshteĭn IuA; Antonenko SV; Marichev IL
    Tsitol Genet; 1993; 27(6):97-104. PubMed ID: 8066812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection.
    O'Connor DH; Allen TM; Vogel TU; Jing P; DeSouza IP; Dodds E; Dunphy EJ; Melsaether C; Mothé B; Yamamoto H; Horton H; Wilson N; Hughes AL; Watkins DI
    Nat Med; 2002 May; 8(5):493-9. PubMed ID: 11984594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV escape: there and back again.
    Altman JD; Feinberg MB
    Nat Med; 2004 Mar; 10(3):229-30. PubMed ID: 14991039
    [No Abstract]   [Full Text] [Related]  

  • 18. Human and simian immunodeficiency virus-infected chimpanzees do not have increased intracellular levels of beta-chemokines in contrast to infected humans.
    Ondoa P; Vereecken C; Fransen K; Colebunders R; van der Groen G; Heeney JL; Kestens L
    J Med Virol; 2003 Mar; 69(3):297-305. PubMed ID: 12526038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIDS vaccine models: challenging challenge viruses.
    Feinberg MB; Moore JP
    Nat Med; 2002 Mar; 8(3):207-10. PubMed ID: 11875482
    [No Abstract]   [Full Text] [Related]  

  • 20. CD8 lymphocytes in HIV infection: helpful and harmful.
    Famularo G; Moretti S; Marcellini S; Nucera E; De Simone C
    J Clin Lab Immunol; 1997; 49(1):15-32. PubMed ID: 9819670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.